1Pistachio Safety Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
2Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
3College of Nursing, Al-Kitab University, Kirkuk, Iraq
4Student Research Committee, Razi Faculty of Nursing and Midwifery, Kerman University of Medical Sciences, Kerman, Iran
5Nursing Research Center, Kerman University of Medical Sciences, Kerman, Iran
6Department of Critical Care, Faculty of Nursing and Midwifery, Kerman University of Medical Sciences, Kerman, Iran
© 2024 The Korean Society of Critical Care Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
FUNDING
None.
AUTHOR CONTRIBUTIONS
Conceptualization: ER, MD. Methodology: ER, MD. Formal analysis: MD. Data curation: ER. Project administration: ER, MD. Writing–original draft: MAZ. Writing–review & editing: MAZ, MD, ARA.
Variable | ROM exercise group | Massage group | Control group | Chi-square test | P-value |
---|---|---|---|---|---|
ICU-AW before intervention | 0.68 | 0.71 | |||
YES | 12 (80.0) | 11 (73.3) | 10 (66.7) | ||
NO | 3 (20.0) | 4 (26.7) | 5 (33.3) | ||
ICU-AW after intervention | 35.00a) | <0.001 | |||
YES | 0 | 3 (20.0) | 15 (100.0) | ||
NO | 15 (100.0) | 12 (80.0) | 0 | ||
McNemar's test | 20.00 | 8.57 | 6.00 | ||
P-value | <0.001 | 0.009 | 0.042 |
Variable | ROM exercise group (n=15) | Massage group (n=15) | Control group (n=15) | Test statistic | P-value |
---|---|---|---|---|---|
Age (yr) | 41±14 | 52±14 | 52±16 | F=2.71 | 0.081 |
Glascow coma scale score | 15 | 15 | 15 | - | - |
FOUR score | 14.5±0.5 | 14.4±0.6 | 14.9±0.4 | F=2.13 | 0.132 |
APACHE II score | 5.7±2.2 | 6.8±2.5 | 9.3±3.4 | F=6.50 | 0.003 |
SOFA score | 1.7±1.3 | 2.3±1.3 | 2.1±1.5 | F=0.64 | 0.533 |
Sex | χ2=0.18 | 0.924 | |||
Male | 7 (46.7) | 7 (46.7) | 8 (53.3) | ||
Female | 8 (53.3) | 8 (53.3) | 7 (46.7) | ||
Length of hospital stay before ICU admission (day) | Fisher’s exact test=8.19 | 0.123 | |||
1 | 8 (53.3) | 11 (73.3) | 5 (33.3) | ||
2 | 6 (40.0) | 3 (20.0) | 9 (60.0) | ||
3 | 1 (6.7) | 1 (6.7) | - | ||
4 | - | - | 1 (6.7) | ||
History of addiction | χ2=1.45 | 0.481 | |||
Yes | 3 (20.0) | 5 (33.3) | 6 (40.0) | ||
No | 12 (80.0) | 10 (66.7) | 9 (60.0) | ||
History of ICU admission | Fisher’s exact test=1.86 | >0.99 | |||
Yes | - | - | 1 (6.7) | ||
No | 15 (100) | 15 (100) | 14 (93.3) | ||
Use of renal replacement therapy | Fisher’s exact test=2.81 | 0.323 | |||
Yes | - | - | 2 (13.3) | ||
No | 15 (100) | 15 (100) | 13 (86.7) | ||
Respiratory support | Fisher’s exact test=6.30 | 0.371 | |||
Simple mask | - | - | 1 (6.7) | ||
Mask without inhalation of exhaled air | 8 (53.3) | 5 (33.3) | 3 (20.0) | ||
Invasive mechanical ventilation | 2 (13.3) | 1 (6.7) | 3 (20.0) | ||
High flow device | 5 (33.3) | 9 (60.0) | 8 (53.3) |
Muscle group | ROM exercise group (n=15, a) | Massage group (n=15, b) | Control group (n=15, c) | Between P-value | ANCOVA F (P-value), effect size post-hoc | |
---|---|---|---|---|---|---|
Right deltoid | Pre | 11.6±2.8 | 8.7±3.3 | 11.5±1.7 | 0.007 | |
Post | 12.4±2.7 | 9.1±3.2 | 10.7±1.9 | 0.007 | ||
Difference | 0.8±0.3 | 0.4±0.3 | –0.8±0.5 | 37.37 (<0.001) | ||
t | 11.3 | 4.6 | –5.8 | 0.65 | ||
P-value | <0.001 | <0.001 | <0.001 | a>b>c | ||
Left deltoid | Pre | 11.5±2.8 | 8.6±3.3 | 11.4±1.7 | 0.006 | |
Post | 12.3±2.8 | 9.0±3.2 | 10.7±1.9 | 0.008 | ||
Difference | 0.8±0.2 | 0.5±0.4 | –0.7±0.5 | 36.06 (<0.001) | ||
t | 12.9 | 5 | –5.5 | 0.64 | ||
P-value | <0.001 | <0.001 | <0.001 | a>b>c | ||
Right wrist | Pre | 6.7±1.1 | 5.6±1.4 | 6.4±1.1 | 0.040 | |
Post | 7.4±1.1 | 6.0±1.3 | 6.1±1.1 | 0.003 | ||
Difference | 0.6±0.2 | 0.4±0.3 | –0.3±0.3 | 33.19 (<0.001) | ||
t | 10.0 | 5.2 | –3.6 | 0.62 | ||
P-value | <0.001 | <0.001 | 0.003 | a>b>c | ||
Left wrist | Pre | 6.7±1.1 | 5.5±1.4 | 6.4±1.0 | 0.020 | |
Post | 7.3±1.1 | 5.9±1.3 | 6.0±1.0 | 0.003 | ||
Difference | 0.6±0.2 | 0.4±0.3 | –0.4±0.3 | 29.21 (<0.001) | ||
t | 9.2 | 4.6 | –4.1 | 0.59 | ||
P-value | <0.001 | <0.001 | 0.001 | a>b>c | ||
Right biceps | Pre | 12.9±2.3 | 9.5±3.3 | 11.6±2.1 | 0.003 | |
Post | 13.6±2.2 | 9.8±3.3 | 11.0±2.1 | 0.001 | ||
Difference | 0.7±0.2 | 0.3±0.3 | –0.6±0.4 | 48.34 (<0.001) | ||
t | 11.8 | 4.5 | –6.1 | 0.71 | ||
P-value | <0.001 | <0.001 | <0.001 | a>b>c | ||
Left biceps | Pre | 12.8±2.3 | 9.3±3.4 | 11.7±2.0 | 0.002 | |
Post | 13.5±2.4 | 9.7±3.3 | 11.0±2.1 | 0.001 | ||
Difference | 0.7±0.3 | 0.4±0.3 | –0.7±0.4 | 42.88 (<0.001) | ||
t | 9.0 | 5.0 | –6.3 | 0.68 | ||
P-value | <0.001 | <0.001 | <0.001 | a>b>c |
Muscle group | ROM exercise group (n=15, a) | Massage group (n=15, b) | Control group (n=15, c) | Between P-value | ANCOVA F (P-value), effect size post-hoc | |
---|---|---|---|---|---|---|
Right recuts | Pre | 14.9±1.6 | 12.6±2.7 | 12.1±1.2 | 0.001 | |
Post | 15.5±1.5 | 13.0±2.6 | 11.2±1.5 | <0.001 | ||
Difference | 0.7±0.3 | 0.4±0.3 | –0.9±0.5 | 57.71 (<0.001) | ||
t | 7.67 | 5.42 | –6.89 | 0.74 | ||
P-value | <0.001 | <0.001 | <0.001 | a>b>c | ||
Left rectus | Pre | 14.8±1.6 | 12.6±2.6 | 12.2±1.3 | 0.001 | |
Post | 15.4±1.6 | 12.9±2.6 | 11.2±1.5 | <0.001 | ||
Difference | 0.7±0.3 | 0.3±0.3 | –1.0±0.4 | 63.77 (<0.001) | ||
t | 8.11 | 4.63 | –8.77 | 0.76 | ||
P-value | <0.001 | <0.001 | <0.001 | a>b>c | ||
Right tibialis | Pre | 7.0±1.5 | 6.47±1.2 | 7.1±1.6 | 0.036 | |
Post | 7.6±1.5 | 6.7±1.4 | 6.5±1.8 | 0.11 | ||
Difference | 0.6±0.2 | 0.3±0.3 | –0.6±0.4 | 48.94 (<0.001) | ||
t | 11.44 | 4.79 | –5.76 | 0.71 | ||
P-value | <0.001 | <0.001 | <0.001 | a>b>c | ||
Left tibialis | Pre | 7.0±1.5 | 6.2±1.3 | 7.0±1.5 | 0.28 | |
Post | 7.6±1.4 | 6.6±1.4 | 6.4±1.8 | 0.07 | ||
Difference | 0.6±0.3 | 0.3±0.3 | –0.6±0.5 | 29.96 (<0.001) | ||
t | 9.60 | 4.07 | –5.06 | 0.6 | ||
P-value | <0.001 | 0.001 | <0.001 | a>b>c | ||
Right quadriceps | Pre | 15.2±1.5 | 13.4±2.9 | 12.3±1.9 | 0.003 | |
Post | 15.8±1.5 | 13.6±2.9 | 11.4±2.07 | <0.001 | ||
Difference | 0.6±0.3 | 0.3±0.2 | –0.9±0.5 | 55.52 (<0.001) | ||
t | 8.37 | 6.37 | –7.14 | 0.74 | ||
P-value | <0.001 | <0.001 | <0.001 | a>b>c | ||
Left quadriceps | Pre | 15.2±1.5 | 13.4±2.8 | 12.4±1.8 | 0.003 | |
Post | 15.8±1.6 | 13.6±3.0 | 11.5±2.0 | <0.001 | ||
Difference | 0.6±0.2 | 0.2±0.3 | –0.9±0.4 | 72.01 (<0.001) | ||
t | 13.14 | 3.3 | –9.13 | 0.78 | ||
P-value | <0.001 | 0.005 | <0.001 | a>b>c |
Variable | ROM exercise group | Massage group | Control group | Kruskal-Wallis test | P-value | Effect size |
---|---|---|---|---|---|---|
MRC score before intervention | 45.9±4.0 | 46.8±4.8 | 50.0±3.3 | 5.86 | 0.053 | 1.77 |
MRC score after intervention | 45.9±4.1 | 46.8±4.8 | 50.0±3.3 | 31.84 | <0.001 | 6.86 |
Wilcoxon test (P-value) | –3.44 (0.001) | –3.42 (0.001) | –3.44 (0.001) | - | - | - |
Mean difference | 12.0±2.3 | 6.3±3.0 | –8.5±2.4 | 37.62 | <0.001 | 8.62 |
Variable | ROM exercise group | Massage group | Control group | Chi-square test | P-value |
---|---|---|---|---|---|
ICU-AW before intervention | 0.68 | 0.71 | |||
YES | 12 (80.0) | 11 (73.3) | 10 (66.7) | ||
NO | 3 (20.0) | 4 (26.7) | 5 (33.3) | ||
ICU-AW after intervention | 35.00 |
<0.001 | |||
YES | 0 | 3 (20.0) | 15 (100.0) | ||
NO | 15 (100.0) | 12 (80.0) | 0 | ||
McNemar's test | 20.00 | 8.57 | 6.00 | ||
P-value | <0.001 | 0.009 | 0.042 |
Values are presented as mean±standard deviation or number (%). ROM: range of motion; FOUR: Full Outline of Unresponsiveness; APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; ICU: intensive care unit.
Values are presented as mean±standard deviation. Control variables of ANCOVA: pre-muscle strength, Acute Physiology and Chronic Health Evaluation II score. ROM: range of motion; ANCOVA: analysis of covariance.
Values are presented as mean±standard deviation. Control variables of ANCOVA: pre-muscle strength, Acute Physiology and Chronic Health Evaluation II score. ROM: range of motion; ANCOVA: analysis of covariance.
Values are presented as mean±standard deviation unless otherwise indicated. MRC: Medical Research Council; ROM: range of motion.
Values are presented as number (%). ICU-AW: intensive care unit acquired weakness; ROM: range of motion. Fisher's exact test.